Bleeding caused by Hemophilia A (DBCOND0089512)

Identifiers

Synonyms
Not Available

Associated Data

Indicated Drugs and Targets
DrugDescriptionTargets
Anti-inhibitor coagulant complex
A medication used to control bleeding episodes and prevent bleeding episodes in hemophilia A and B.
Coagulation factor VIIa Recombinant Human
A form of recombinant human coagulation Factor VII used to treat hemophilia A and B.
Emicizumab
An antibody against Factor IXa and Factor X used to treat hemophilia A.
Moroctocog alfa
A recombinant Factor VIII used to treat hemophilia A to control bleeding.
Rurioctocog alfa pegol
A pegylated recombinant human coagulation factor VIII used to treat and prevent bleeding episodes in patients 12 years and above with hemophilia A.
Simoctocog alfa
An antihemorrhagic agent used for the treatment and prophylaxis of bleeding in patients of all ages with haemophilia A (congenital factor VIII deficiency).
Turoctocog alfa pegol
Turoctocog alfa pegol is indicated for use in adults and children with hemophilia A for on-demand treatment and control of bleeding episodes, perioperative management of bleeding, and routine prophylaxis to...
Clinical Trials
Not Available